Amelioration of Amyloid‐β Induced Alzheimer's Disease by Bacopa monnieri through Modulation of Mitochondrial Dysfunction and GSK‐3β/Wnt/β‐Catenin Signaling
The DOI matches its Crossref record; 62 of the 65 references it cites were found in a registry or an index.
Abstract
Background: Alzheimer's disease (AD) is the most prevalent dementia, affecting a large number of populations. Despite being under scrutiny for decades, an effective therapeutic option is still not available. Methods and results: This study explores the therapeutic role of a nootropic herb Bacopa monnieri (BM) in AD‐like pathological conditions produced by injecting preformed amyloid‐β 42 (Aβ 42 ) fibril bilaterally into hippocampus of Wistar rats, and ethanolic extract of BM is orally administered for 4 weeks. Assessment of behavioral changes reveals that BM treatment ameliorates Aβ 42 ‐induced cognitive impairment and compromised explorative behavior. Supplementation of BM also reduces oxidative stress biomarkers, proinflammatory cytokines, and cholinesterase activity in the AD rats. Additionally, BM treatment restores Bcl‐2‐associated X protein (Bax)/ B‐cell lymphoma 2 (Bcl‐2) imbalance, increases neurotrophic factors expression, and prevents neurodegeneration validated by quantifying Nissl‐positive hippocampal neurons. Interestingly, BM administration eliminates amyloid plaques in the hippocampal region and normalizes the Aβ 42 ‐induced increase in phospho‐tau and total tau expression. Mechanistic investigations reveal that BM interacts with glycogen synthase kinase (GSK‐3β) and restores Wnt/β‐catenin signaling. Conclusion: BM has been used in diet as a nootropic herb for several centuries. This study highlights the anti‐Alzheimer activity of BM from the behavioral to the molecular level by modulating mitochondrial dysfunction, and GSK‐3β mediates the Wnt/β‐catenin signaling pathway.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Bacopa monnieri extract (40–80 mg/kg) reduced Alzheimer’s-like symptoms in Aβ42-injected rats by improving cognitive function, preserving hippocampal neurons, modulating the GSK-3β/Wnt/β-catenin pathway, and significantly decreasing AChE activity at 80 mg/kg [78].”
From Cholinesterase Inhibitors from Plants and Their Potential in Alzheimer’s Treatment: Systematic Review (2025) · cites this paper as [78]
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
The amyloid hypothesis of Alzheimer's disease at 25 years
Selkoe, D. J., & Hardy, J. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606210 · Cited by 6,164
Determination of malonaldehyde precursor in tissues by thiobarbituric acid test
Uchiyama, M., & Mihara, M. (1978) · Analytical Biochemistry · doi:10.1016/0003-2697(78)90342-1 · Cited by 5,188
AChE-stained horizontal sections of the rat brain in stereotaxic coordinates
Paxinos, G., Watson, C. R. R., & Emson, P. C. (1980) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(80)90021-7 · Cited by 4,497
Jollow, D. J., Mitchell, J. R., Zampaglione, N., & Gillette, J. R. (2008) · Pharmacology · doi:10.1159/000136485 · Cited by 3,285
Gabedit—A graphical user interface for computational chemistry softwares
Allouche, A. (2011) · Journal of Computational Chemistry · doi:10.1002/jcc.21600 · Cited by 2,460
2022 Alzheimer's disease facts and figures
(2022) · Alzheimer's & Dementia · doi:10.1002/alz.12638 · Cited by 2,341
CRC handbook of methods for oxygen radical research
Bogomolets, B. B. (1985) · Experimental Gerontology · doi:10.1016/0531-5565(85)90021-x · Cited by 1,546
Mechanisms of cytochrome c release from mitochondria
Garrido, C., Galluzzi, L., Brunet, M., Puig, P. E., Didelot, C., & Kroemer, G. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401950 · Cited by 1,390
Cold Spring Harbor Perspectives in Biology
(2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect_biol/ · Cited by 942
Research works printed but not linked: 7
- Goswami S., 2011, Int. J. Collab. Res. Intern. Med. Public Health, 3, 285
- Lueptow L. M., 2017, J. Vis. Exp., 2017
- Nunez J., 2008, J. Vis. Exp., 19, 897
- Case D. A., 2018, Amber 2018 Reference Manual
- Tembhre M., 2016, Pharm. Pharmacol. Int. J., 4, 413
- Holmes C., 2017, Dementia, 14, 508
- Wetchateng T., 2015, J. Med. Assoc. Thai., 98, 56
Cited by
Valotto Neto, L. J., Reverete de Araujo, M., Moretti Junior, R. C., Mendes Machado, N., Joshi, R. K., dos Santos Buglio, D., Barbalho Lamas, C., Direito, R., Fornari Laurindo, L., Tanaka, M., et al. (2024) · Antioxidants · doi:10.3390/antiox13040393 · Cited by 146
“However, an imbalance in the generation and neutralization of ROS can accumulate harmful intermediate products and cause OS, leading to brain damage [35,145–150].”
InfluentialUti, D. E., Alum, E. U., Atangwho, I. J., Ugwu, O. P.-C., Egbung, G. E., & Aja, P. M. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03412-z · Cited by 115
Jiang, M., Chi, J., Qiao, Y., Wang, J., Zhang, Z., Liu, J., Sheng, X., & Yuan, L. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107578 · Cited by 72
Faraji, N., Ebadpour, N., Abavisani, M., & Gorji, A. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04462-4 · Cited by 42
ALNasser, M. N., Alboraiy, G. M., Alsowig, E. M., & Alqattan, F. M. (2025) · Brain Sciences · doi:10.3390/brainsci15020215 · Cited by 35
Metadata
- Authors
- Sushma, Sahu, M. R., Murugan, N. A., & Mondal, A. C.
- Affiliations
- Jawaharlal Nehru University (IN)
- Indraprastha Institute of Information Technology Delhi (IN)
- Corresponding author
- Mondal, Amal Chandra
- Venue
- Molecular Nutrition & Food Research
- Publisher
- Wiley
- Published
- 2023-12-24
- Volume
- 68
- Issue
- 13
- Pages
- e2300245-e2300245
- ISSN
- 1613-4125 (ISSN-L)
- 1613-4133
- OpenAlex
- W4390197753
- Cited by
- 17
- References
- 65
- Citations by year
- 2026: 6 · 2025: 6 · 2024: 5
- FWCI
- 5.20
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Molecular Nutrition & Food Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Department of Biotechnology, Ministry of Science and Technology, India (BT/PR32907/MED/122/227/2019, BT/PR38493/TRM/120/465/2020)
- Topics
- Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plants and Neuroprotection
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Pharmacology (medical) › Cholinesterase and Neurodegenerative Diseases
- Keywords
- Alzheimer's disease, Bacopa monnieri, amyloid-beta 42, GSK3β, Wnt/β-catenin signaling, mitochondrial dysfunction, oxidative stress, neuroinflammation, cholinesterase activity, tau phosphorylation, amyloid plaques, hippocampus, cognitive impairment, neuroprotection
- MeSH terms
- Glycogen Synthase Kinase 3 beta, Alzheimer Disease, Animals, Disease Models, Animal, Hippocampus, Male, Mitochondria, Peptide Fragments, Plant Extracts, Amyloid beta-Peptides, Rats, Wistar, Oxidative Stress, Bacopa, beta Catenin, Rats, Wnt Signaling Pathway
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Amelioration of Amyloid‐β Induced Alzheimer's Disease by Bacopa monnieri through Modulation of Mitochondrial Dysfunction and GSK‐3β/Wnt/β‐Catenin Signaling. https://app.cochat.ai/papers/10.1002/mnfr.202300245
- The paper
- Sushma, Sahu, M. R., Murugan, N. A., & Mondal, A. C. (2024). Amelioration of Amyloid‐β Induced Alzheimer's Disease by Bacopa monnieri through Modulation of Mitochondrial Dysfunction and GSK‐3β/Wnt/β‐Catenin Signaling. Molecular Nutrition & Food Research. https://doi.org/10.1002/mnfr.202300245
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.